Chronic Pancreatitis (CP) Global Market Report 2025
상품코드:1826896
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
만성 췌장염(CP) 시장 규모는 최근 몇 년 동안 강력하게 성장하고 있습니다. 2024년 49억 1,000만 달러에서 2025년에는 52억 3,000만 달러에 달하고, CAGR 6.4%를 나타낼 전망입니다. 실적기간의 성장은 알코올 섭취 유병률 증가, 흡연률 상승, 유전적 소인과 가족력, 췌장 질환에 대한 의식 증가, 췌장염과 관련된 당뇨병의 증례 증가, 헬스케어 지출 증가, 헬스케어 서비스 접근성 개선 등에 기인할 수 있습니다.
만성 췌장염(CP) 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 66억 6,000만 달러로 성장하며 CAGR은 6.2%를 나타낼 전망입니다. 예측기간 성장의 배경으로는 노인 인구 증가, 효소 보충 요법에 대한 수요 증가, 조기 진단에 대한 의식 증가, 신흥국 시장의 건강 관리 인프라 확충, 신규 통증 관리 요법 개발, 췌장염 치료에 관한 연구 및 임상시험 증가가 있습니다. 예측기간의 주요 동향으로는 영상 진단에 있어서의 인공지능, 최소 침습 수술 기술, 지속적인 건강 모니터링을 위한 웨어러블, 유전자 검사를 위한 차세대 시퀀서, 질병 진행 추적에 있어서의 머신러닝의 통합, 스마트 진단 툴의 개발 등을 들 수 있습니다.
만성 췌장염(CP)은 췌장의 지속성, 진행성 염증성 질환으로 돌이킬 수없는 구조적 및 기능적 손상을 초래합니다. 만성 췌장염은 진행성 염증, 섬유화(흉터), 췌장 소화 효소 및 인슐린과 같은 호르몬 생산 능력의 점감을 특징으로합니다.
만성 췌장염의 주요 치료법에는 진통제, 인공 소화 효소, 단백질 보충제, 스테로이드, 항생제 등이 있습니다. 진통제는이 증상의 일반적인 증상 인 통증을 관리하는 데 도움이 됩니다. 진단 방법으로는 컴퓨터 단층 촬영(CT) 스캔, 자기 공명 담관 췌관 조영술, 초음파 소노그래피 등이 있습니다. 치료의 투여 경로는 경구 및 비경구이며, 최종 사용자는 병원, 홈 케어, 기타 건강 관리 제공업체 등입니다.
2025년 봄 미국 관세의 급상승과 이에 따른 무역 마찰은 의료 분야, 특히 필수적인 의료기기, 진단 장비 및 의약품 공급에 큰 영향을 미쳤습니다. 병원과 건강 관리 제공업체는 수입되는 수술 기구, 영상 진단 시스템, 주사기 및 카테터와 같은 소모품의 비용 상승에 시달리고 있으며, 그 대부분은 국내 대체품이 제한되어 있습니다. 이러한 비용 상승이 의료 예산을 압박하기 때문에 일부 의료기관은 장비 업그레이드를 늦추거나 비용 증가를 환자에게 전가하고 있습니다. 게다가 원료와 부품에 대한 관세는 중요한 의약품과 의료기기의 제조에 지장을 주고 공급망의 지연으로 이어지고 있습니다. 이에 비해 업계는 다양한 조달 전략을 채택하고 가능한 한 현지 생산을 확대하고 중요한 의료 제품의 관세 면제를 수행하고 있습니다.
이 조사 보고서는 만성 췌장염(CP) 산업 세계 시장 규모, 지역 점유율, 만성 췌장염(CP) 시장 점유율을 가진 경쟁업체, 상세한 만성 췌장염(CP) 시장 부문, 시장 동향 및 비즈니스 기회, 만성 췌장염(CP) 업계에서 성공하는 데 필요한 데이터 등, 만성 췌장염(CP) 시장 통계를 제공합니다. 이 만성 췌장염(CP) 시장 조사 보고서는 업계의 현재 및 미래 시나리오를 자세히 분석하고 필요한 모든 것을 완벽한 관점에서 제공합니다.
향후 5년간의 성장률 6.2%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 일본과 덴마크에서 수입되는 췌장 효소 보충제와 초음파 내시경 스코프의 비용을 상승시키고 영양 불량의 결과를 악화시킬 가능성과 소화기 수술의 비용을 상승시킴으로써 미국의 췌장 의료를 혼란시킬 가능성이 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
알코올 소비 증가는 앞으로 수년간 만성 췌장염(CP) 시장 성장을 가속할 것으로 예측됩니다. 알코올 소비는 에탄올을 포함한 음료의 섭취를 포함하며, 종종 레크리에이션, 사회적, 문화적 이유로 인한 것이지만, 과도한 사용은 중독과 건강 합병증을 유발할 수 있습니다. 사회적 수용의 확대, 도시화, 라이프 스타일의 진화, 특히 젊은층의 스트레스 관리 습관 등의 요인이 알코올 소비의 확대에 기여하고 있습니다. 알코올 유발성 만성 췌장염은 췌장 세포의 염증과 손상으로 인해 발생하며, 섬유화, 관폐색 및 독성 대사 제품별로 장기적인 기능 장애를 일으킬 수 있습니다. 예를 들어, 2023년 12월 일본에 본사를 둔 맥주 및 음료 지주회사인 기린홀딩스(Kirin Holdings Company Limited)의 발표에 따르면, 2022년 전 세계 맥주 소비량은 2021년 대비 약 540만 킬로리터(633ml 병 약 85억 개에 해당) 증가하여 약 1억 9,210만 킬로리터에 달했습니다. 이 2.9% 증가는 COVID-19의 영향이 완화된 것에 의한 것으로, 633ml 병으로 약 3,035억개에 해당합니다. 그 결과, 알코올 소비 증가가 만성 췌장염(CP) 시장 확대에 박차를 가하고 있습니다.
만성 췌장염(CP) 시장 주요 기업은 만성 췌장염과 관련된 췌장 외분비 기능 장애(EPI)를 다루기 위해 효소 보충 요법과 같은 기술 진보에 투자하고 있습니다. 효소 보충 요법은 췌장 기능이 감소한 환자의 소화를 지원하기 위해 췌장 효소를 경구 투여하는 것입니다. 예를 들어, 2023년 7월 미국 기반 임상 단계 바이오의약품 기업인 퍼스트 웨이브 바이오파마(First Wave BioPharma Inc.)는 낭포성 섬유증(CF) 및 만성 췌장염 환자의 EPI 치료를 위한 아드루리파제(adrulipase)의 고급 장용성 미세과립 제형 전달 방식을 평가한 2상 SPAN 임상시험 결과를 발표했습니다. 야로위아 리폴리티카(Yarrowia lipolytica) 효모에서 유래한 재조합 리파제 효소인 아드루리파제는 경구용 비전신 생물학적 캡슐 형태로 투여되며, EPI 환자의 소화관에서 지방 분자를 분해하여 영양소 흡수를 가능하게 합니다.
2023년 3월 미국에 본사를 둔 임상 단계 바이오 의약품 회사인 카르티메디카는 비공개 금액으로 그레이버그 비전과 합병했습니다. 이 합병은 역 거래로 구성되어 생명을 위협하는 염증성 질환의 치료제 개발에 있어서의 카르티메디카의 대처를 강화하는 것입니다. Graybug Vision Inc.는 미국에 본사를 둔 임상 단계의 바이오 의약품 회사로 췌장염을 비롯한 심각한 염증성 질환의 치료법 개발에 주력하고 있습니다.
만성 췌장염(CP) 시장은 만성 췌장염의 진단과 관리를 위해 영상 진단, 내시경 치료, 통증 관리, 영양 상담, 원격 의료 서비스 등의 서비스를 제공하는 기업이 얻는 수익으로 구성됩니다. 시장 가치에는 서비스 제공업체가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 만성 췌장염(CP) 시장에는 효소 보충 요법, 통증 관리제, 항 염증 치료제, 생물학적 제제, 줄기 세포 요법, 수술 개입, 영상 검사 및 임상 검사와 같은 진단 도구의 판매도 포함됩니다. 이 시장의 가치는 '팩토리 게이트'의 가치입니다. 즉, 다른 기업(다운스트림 제조업자, 도매업체, 유통업체, 소매업체 포함)이든 직접 최종 고객이든, 상품의 제조자 또는 제조자가 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품 제작자에 의해 판매되는 관련 서비스도 포함됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 만성 췌장염(CP) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 만성 췌장염(CP) 시장 : 성장률 분석
세계의 만성 췌장염(CP) 시장 실적 : 규모와 성장(2019-2024년)
세계의 만성 췌장염(CP) 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 만성 췌장염(CP) : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 만성 췌장염(CP) 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진통제
인공 소화 효소
단백질 보충제
스테로이드
항생제
기타 치료법
세계의 만성 췌장염(CP) 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
컴퓨터 단층촬영(CT) 스캔
자기공명 담관췌관조영술
초음파 검사
기타 진단
세계의 만성 췌장염(CP) 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
비경구
세계의 만성 췌장염(CP) 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
홈케어
기타 최종 사용자
세계의 만성 췌장염(CP) 시장 : 진통제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
비스테로이드성 항염증제(NSAIDs)
오피오이드
세계의 만성 췌장염(CP) 시장 : 인공 소화 효소 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
판크레리파제
판크레아틴
세계의 만성 췌장염(CP) 시장 : 단백질 보충제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
분지 사슬 아미노산(BCAA)
유청 단백질
세계의 만성 췌장염(CP) 시장 : 스테로이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
프레드니손
덱사메타손
세계의 만성 췌장염(CP) 시장 : 항생제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
시프로플록사신
메트로니다졸
세계의 만성 췌장염(CP) 시장 : 기타 치료법 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
내시경 치료
수술
제7장 지역별/국가별 분석
세계의 만성 췌장염(CP) 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 만성 췌장염(CP) 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
만성 췌장염(CP) 시장 : 경쟁 구도
만성 췌장염(CP) 시장 : 기업 프로파일
Pfizer : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bristol-Myers Squibb
Abbott Laboratories
Novartis AG
GlaxoSmithKline plc
Baxter
CSL Behring
Octapharma AG
Dr. Reddy's Laboratories
Nestle Health Science
Cerata Pharmaceuticals
Unichem Laboratories Ltd
LGM Pharma
Aptalis Pharmaceutical Technologies
Digestive Care Inc
Akron Biotech
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
만성 췌장염(CP) 시장(2029년) : 새로운 기회를 제공하는 국가
만성 췌장염(CP) 시장(2029년) : 새로운 기회를 제공하는 부문
만성 췌장염(CP) 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Chronic pancreatitis (CP) is a persistent, progressive inflammatory disorder of the pancreas that leads to irreversible structural and functional damage. It is characterized by ongoing inflammation, fibrosis (scarring), and the gradual loss of the pancreas's ability to produce digestive enzymes and hormones such as insulin.
The primary treatment options for chronic pancreatitis include analgesics, artificial digestive enzymes, protein supplements, steroids, antibiotics, and others. Analgesics help manage pain, a common symptom of the condition. Diagnosis methods include computed tomography (CT) scans, magnetic resonance cholangiopancreatography, ultrasound sonography, and others. The routes of administration for treatments are oral and parenteral, with end users including hospitals, home care, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The chronic pancreatitis (CP) market research report is one of a series of new reports from The Business Research Company that provides chronic pancreatitis (CP) market statistics, including chronic pancreatitis (CP) industry global market size, regional shares, competitors with a chronic pancreatitis (CP) market share, detailed chronic pancreatitis (CP) market segments, market trends and opportunities, and any further data you may need to thrive in the chronic pancreatitis (CP) industry. This chronic pancreatitis (CP) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic pancreatitis (cp) market size has grown strongly in recent years. It will grow from $4.91 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to the increasing prevalence of alcohol consumption, rising incidence of smoking, genetic predisposition and family history, growing awareness of pancreatic diseases, rising cases of diabetes linked to pancreatitis, increasing healthcare spending, improved access to healthcare services.
The chronic pancreatitis (cp) market size is expected to see strong growth in the next few years. It will grow to $6.66 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the rising geriatric population, increasing demand for enzyme replacement therapies, growing awareness of early diagnosis, expansion of healthcare infrastructure in emerging markets, development of novel pain management therapies, increasing research and clinical trials for pancreatitis treatment. Major trends in the forecast period include artificial intelligence in diagnostic imaging, minimally invasive surgical techniques, wearables for continuous health monitoring, next-generation sequencing for genetic testing, integration of machine learning in disease progression tracking, and the development of smart diagnostic tools.
The forecast of 6.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pancreatic care by increasing costs for pancreatic enzyme replacements and endoscopic ultrasound scopes imported from Japan and Denmark, potentially worsening malnutrition outcomes and raising gastroenterology procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising consumption of alcohol is anticipated to drive the growth of the chronic pancreatitis market in the coming years. Alcohol consumption involves the intake of ethanol-containing beverages, often for recreational, social, or cultural reasons, but excessive use can lead to dependency and health complications. Factors such as increasing social acceptance, urbanization, evolving lifestyles, and stress management practices, particularly among younger demographics, contribute to the growing consumption of alcohol. Alcohol-induced chronic pancreatitis occurs due to inflammation and damage to pancreatic cells, resulting in fibrosis, ductal blockages, and long-term dysfunction caused by toxic metabolic byproducts. For example, in December 2023, a publication by Kirin Holdings Company Limited, a Japan-based beer and beverage holding company, reported that total global beer consumption in 2022 increased by approximately 5.4 million kiloliters (equivalent to around 8.5 billion 633ml bottles) compared to 2021, reaching around 192.1 million kiloliters. This 2.9% increase was attributed to the easing of COVID-19's impact, amounting to roughly 303.5 billion 633ml bottles. As a result, the rising consumption of alcohol is fueling the expansion of the chronic pancreatitis market.
Leading companies in the chronic pancreatitis market are investing in technological advancements such as enzyme replacement therapy to address exocrine pancreatic insufficiency (EPI) associated with chronic pancreatitis. Enzyme replacement therapy involves administering oral pancreatic enzymes to support digestion in individuals with impaired pancreatic function. For instance, in July 2023, First Wave BioPharma Inc., a US-based clinical-stage biopharmaceutical company, announced results from the Phase 2 SPAN clinical trial evaluating an advanced enteric microgranule delivery formulation of adrulipase for treating EPI in patients with cystic fibrosis (CF) and chronic pancreatitis. Adrulipase, a recombinant lipase enzyme derived from Yarrowia lipolytica yeast, is administered as an oral, non-systemic biologic capsule designed to break down fat molecules in the digestive tract of EPI patients, enabling nutrient absorption.
In March 2023, CalciMedica Inc., a US-based clinical-stage biopharmaceutical company, merged with Graybug Vision Inc. for an undisclosed amount. This merger, structured as a reverse transaction, strengthens CalciMedica's efforts in developing therapies for life-threatening inflammatory diseases. Graybug Vision Inc. is a US-based clinical-stage biopharmaceutical company focused on advancing treatments for severe inflammatory diseases, including pancreatitis.
Major players in the chronic pancreatitis (CP) market are Pfizer, Johnson & Johnson, Merck & Co Inc, AbbVie Inc, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Baxter, CSL Behring, Octapharma AG, Dr. Reddy's Laboratories, Nestle Health Science, Cerata Pharmaceuticals, Unichem Laboratories Ltd, LGM Pharma, Aptalis Pharmaceutical Technologies, Digestive Care Inc, and Akron Biotech.
North America was the largest region in the chronic pancreatitis (CP) market in 2024. The regions covered in chronic pancreatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the chronic pancreatitis (CP) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic pancreatitis market consists of revenues earned by entities by providing services such as diagnostic imaging, endoscopic procedures, pain management, nutritional counseling, and telemedicine services for the diagnosis and management of chronic pancreatitis. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic pancreatitis market also includes sales of enzyme replacement therapies, pain management drugs, anti-inflammatory treatments, biologics, stem cell therapies, and surgical interventions, as well as diagnostic tools such as imaging and laboratory tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Pancreatitis (CP) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic pancreatitis (cp) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic pancreatitis (cp) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic pancreatitis (cp) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment: Analgesic; Artificial Digestive Enzyme; Protein Supplements; Steroids; Antibiotics; Other Treatments
2) By Diagnosis: Computed Tomography (CT) Scan; Magnetic Resonance Cholangiopancreatography; Ultrasound Sonography; Other Diagnosis
3) By Route Of Administration: Oral; Parenteral
4) By End User: Hospitals; Homecare; Other End Users
Subsegments:
1) By Analgesic: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Opioids
2) By Artificial Digestive Enzyme: Pancrelipase; Pancreatin
3) By Protein Supplements: Branched-Chain Amino Acids (BCAA); Whey Protein
4) By Steroids: Prednisone; Dexamethasone
5) By Antibiotics: Ciprofloxacin; Metronidazole
6) By Other Treatments: Endoscopic Treatment; Surgery
Companies Mentioned: Pfizer; Johnson & Johnson; Merck & Co Inc; AbbVie Inc; Sanofi; Bristol-Myers Squibb; Abbott Laboratories; Novartis AG; GlaxoSmithKline plc; Baxter; CSL Behring; Octapharma AG; Dr. Reddy's Laboratories; Nestle Health Science; Cerata Pharmaceuticals; Unichem Laboratories Ltd; LGM Pharma; Aptalis Pharmaceutical Technologies; Digestive Care Inc; Akron Biotech
3. Chronic Pancreatitis (CP) Market Trends And Strategies
4. Chronic Pancreatitis (CP) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Chronic Pancreatitis (CP) Growth Analysis And Strategic Analysis Framework
5.1. Global Chronic Pancreatitis (CP) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Pancreatitis (CP) Market Growth Rate Analysis
5.4. Global Chronic Pancreatitis (CP) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Pancreatitis (CP) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Pancreatitis (CP) Total Addressable Market (TAM)
6. Chronic Pancreatitis (CP) Market Segmentation
6.1. Global Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analgesic
Artificial Digestive Enzyme
Protein Supplements
Steroids
Antibiotics
Other Treatments
6.2. Global Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Computed Tomography (CT) Scan
Magnetic Resonance Cholangiopancreatography
Ultrasound Sonography
Other Diagnosis
6.3. Global Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.4. Global Chronic Pancreatitis (CP) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Other End Users
6.5. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Analgesic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Opioids
6.6. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Artificial Digestive Enzyme, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pancrelipase
Pancreatin
6.7. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Protein Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Branched-Chain Amino Acids (BCAA)
Whey Protein
6.8. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Dexamethasone
6.9. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ciprofloxacin
Metronidazole
6.10. Global Chronic Pancreatitis (CP) Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Endoscopic Treatment
Surgery
7. Chronic Pancreatitis (CP) Market Regional And Country Analysis
7.1. Global Chronic Pancreatitis (CP) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Pancreatitis (CP) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chronic Pancreatitis (CP) Market
9.1. China Chronic Pancreatitis (CP) Market Overview
9.2. China Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chronic Pancreatitis (CP) Market
10.1. India Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chronic Pancreatitis (CP) Market
11.1. Japan Chronic Pancreatitis (CP) Market Overview
11.2. Japan Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chronic Pancreatitis (CP) Market
12.1. Australia Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chronic Pancreatitis (CP) Market
13.1. Indonesia Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chronic Pancreatitis (CP) Market
14.1. South Korea Chronic Pancreatitis (CP) Market Overview
14.2. South Korea Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chronic Pancreatitis (CP) Market
15.1. Western Europe Chronic Pancreatitis (CP) Market Overview
15.2. Western Europe Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chronic Pancreatitis (CP) Market
16.1. UK Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chronic Pancreatitis (CP) Market
17.1. Germany Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chronic Pancreatitis (CP) Market
18.1. France Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chronic Pancreatitis (CP) Market
19.1. Italy Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chronic Pancreatitis (CP) Market
20.1. Spain Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chronic Pancreatitis (CP) Market
21.1. Eastern Europe Chronic Pancreatitis (CP) Market Overview
21.2. Eastern Europe Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chronic Pancreatitis (CP) Market
22.1. Russia Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chronic Pancreatitis (CP) Market
23.1. North America Chronic Pancreatitis (CP) Market Overview
23.2. North America Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chronic Pancreatitis (CP) Market
24.1. USA Chronic Pancreatitis (CP) Market Overview
24.2. USA Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chronic Pancreatitis (CP) Market
26.1. South America Chronic Pancreatitis (CP) Market Overview
26.2. South America Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chronic Pancreatitis (CP) Market
27.1. Brazil Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chronic Pancreatitis (CP) Market
28.1. Middle East Chronic Pancreatitis (CP) Market Overview
28.2. Middle East Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chronic Pancreatitis (CP) Market
29.1. Africa Chronic Pancreatitis (CP) Market Overview
29.2. Africa Chronic Pancreatitis (CP) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Pancreatitis (CP) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Pancreatitis (CP) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chronic Pancreatitis (CP) Market Competitive Landscape And Company Profiles
